PH20385A - Ergot alkaloids, compositions containing the same and method of use thereof - Google Patents

Ergot alkaloids, compositions containing the same and method of use thereof

Info

Publication number
PH20385A
PH20385A PH29378A PH29378A PH20385A PH 20385 A PH20385 A PH 20385A PH 29378 A PH29378 A PH 29378A PH 29378 A PH29378 A PH 29378A PH 20385 A PH20385 A PH 20385A
Authority
PH
Philippines
Prior art keywords
same
compositions containing
ergot alkaloids
ergot
alkaloids
Prior art date
Application number
PH29378A
Other languages
English (en)
Inventor
Gull Peter
Original Assignee
Sandoz Gull
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Gull filed Critical Sandoz Gull
Publication of PH20385A publication Critical patent/PH20385A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
PH29378A 1982-08-09 1983-08-09 Ergot alkaloids, compositions containing the same and method of use thereof PH20385A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4772/82A CH649998A5 (de) 1982-08-09 1982-08-09 Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff.

Publications (1)

Publication Number Publication Date
PH20385A true PH20385A (en) 1986-12-08

Family

ID=4282273

Family Applications (1)

Application Number Title Priority Date Filing Date
PH29378A PH20385A (en) 1982-08-09 1983-08-09 Ergot alkaloids, compositions containing the same and method of use thereof

Country Status (23)

Country Link
JP (1) JPS5948480A (da)
AT (1) AT383125B (da)
AU (1) AU563736B2 (da)
BE (1) BE897473A (da)
CA (1) CA1215972A (da)
CH (1) CH649998A5 (da)
DE (1) DE3327705A1 (da)
DK (1) DK361983A (da)
ES (1) ES8502992A1 (da)
FI (1) FI73679C (da)
FR (1) FR2531433B1 (da)
GB (1) GB2125041B (da)
GR (1) GR78923B (da)
HU (1) HU187600B (da)
IL (1) IL69450A (da)
IT (1) IT1168961B (da)
MY (1) MY8700166A (da)
NL (1) NL8302776A (da)
NZ (1) NZ205181A (da)
PH (1) PH20385A (da)
PT (1) PT77168B (da)
SE (1) SE8304315L (da)
ZA (1) ZA835850B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
HU193782B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof
FR2589734B1 (fr) * 1985-11-13 1988-09-02 Roussel Uclaf Utilisation de derives de l'ergoline a l'obtention d'un medicament a visee geriatrique
US4798834A (en) * 1987-08-31 1989-01-17 Eli Lilly And Company Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement
DE3913756A1 (de) * 1989-04-21 1990-10-25 Schering Ag 8(beta)-substituierte ergoline, verfahren zu ihrer herstellung und ihre verwendung
DE10212564B4 (de) * 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE41533B1 (en) * 1974-03-14 1980-01-30 Sandoz Ltd Thiomethyl ergolene derivatives
US3901894A (en) * 1974-06-06 1975-08-26 Lilly Co Eli 8-thiomethylergolines
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity

Also Published As

Publication number Publication date
BE897473A (fr) 1984-02-06
DE3327705A1 (de) 1984-02-09
DK361983A (da) 1984-02-10
DK361983D0 (da) 1983-08-08
AU1767283A (en) 1984-02-16
FI73679B (fi) 1987-07-31
IT8322490A0 (it) 1983-08-09
ZA835850B (en) 1985-03-27
SE8304315L (sv) 1984-02-10
CH649998A5 (de) 1985-06-28
IT1168961B (it) 1987-05-20
IL69450A0 (en) 1983-11-30
HU187600B (en) 1986-01-28
PT77168A (en) 1983-09-01
FI832789A (fi) 1984-02-10
MY8700166A (en) 1987-12-31
ES524815A0 (es) 1985-02-01
ATA286383A (de) 1986-10-15
ES8502992A1 (es) 1985-02-01
SE8304315D0 (sv) 1983-08-08
CA1215972A (en) 1986-12-30
NZ205181A (en) 1986-07-11
FR2531433B1 (fr) 1985-10-18
FI832789A0 (fi) 1983-08-02
GB2125041B (en) 1986-04-23
FI73679C (fi) 1987-11-09
GR78923B (da) 1984-10-02
GB8321222D0 (en) 1983-09-07
FR2531433A1 (fr) 1984-02-10
NL8302776A (nl) 1984-03-01
AU563736B2 (en) 1987-07-23
JPS5948480A (ja) 1984-03-19
IL69450A (en) 1986-10-31
GB2125041A (en) 1984-02-29
AT383125B (de) 1987-05-25
PT77168B (en) 1986-03-27

Similar Documents

Publication Publication Date Title
GB8303882D0 (en) Use of quinoline derivatives
PH22672A (en) Imidazolylmethyltetrahydrocarbazolone derivatives, composition and method of use thereof
AU547389B2 (en) Compositions of dextromethorphan and method
ZW20383A1 (en) Compounds compositions and methods of use therefor
PH18959A (en) Novel cephalosporin compounds,compositions containing same and method of use thereof
PH18392A (en) Novel quinolone compounds,compositions containing same and method of use thereof
PH19244A (en) Novel lactobacillus,composition containing same and method of use thereof
PH22998A (en) Ergot peptide alkaloids, pharmaceutical compositions containing them and theit method of use
EP0108147A4 (en) Use of a protoberberine alkaloid and composition containing it.
PH23447A (en) B-actam compounds,pharmaceutical compositions containing the same and method of use thereof
PH19352A (en) Fluoromethylthiooxacephalosporins derivatives compositions containing same and method of use thereof
DE3365136D1 (en) Methods, compositions and elements for the determination of lipase
PH23384A (en) Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions and method use thereof
PH20385A (en) Ergot alkaloids, compositions containing the same and method of use thereof
IL71446A0 (en) Composition and method for the preparation of 1,8-dihydroxy-10-acyl-9-anthrones
GB8319146D0 (en) Formulations of vinca alkaloids
GB8303475D0 (en) Ergot alkaloids
DE3369132D1 (en) Process for the preparation of isomelamines, and their use
JPS56156279A (en) Ergoline derivative, its manufacture and medicinal composition containing it
GB2115811B (en) Ergot alkaloids
CY1298A (en) Pharmaceutical compositions containing ergot alkaloids and heparin
PH23451A (en) Pharmaceutical compositions comprising an hydrogenated ergot alkaloid and heparin
ZA835081B (en) Formulations of vinca alkaloids
GB2092570B (en) Ergot alkaloids
ZA83955B (en) Ergot alkaloids